Great to see our new study “Somatic CpG hypermutation is associated with mismatch repair deficiency in cancer” out t.ly/JgGb3 @UCPH_BRIC @Rigshospitalet together with @sebastianw @EPFL_en and Aidan Flynn @UniMelb Check the cover art 👇t.ly/9fv6l 1/6
link.springer.com Somatic CpG hypermutation is associated with mismatch repair deficiency in cancer Molecular Systems Biology - Somatic hypermutation in cancer has gained momentum with the increased use of tumour mutation burden as a biomarker for immune checkpoint inhibitors. Spontaneous... 
